SCHEMBL381808

SCHEMBL381808

CC(C)(C)N(C(=O)O)C(c1cccc(C(F)(F)F)c1)S(=O)(=O)c1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACP3 P15309 2/20 0.43
CES2 O00748 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
KAT6A Q92794 1/20 0.42
ALDH1A1 P00352 2/20 0.42
CYP3A4 P08684 2/20 0.42
CYP2C9 P11712 2/20 0.42
HPGD P15428 1/20 0.42
CYP2C19 P33261 1/20 0.42
GAA P10253 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
LMNA P02545 1/20 0.41
MEN1 O00255 3/20 0.40
KMT2A Q03164 3/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
MMP1 P03956 1/20 0.40
MMP2 P08253 1/20 0.40
MMP9 P14780 1/20 0.40
MMP8 P22894 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL382440 0.77 HSD11B1 (0.38) ACP3KAT6AALDH1A1MEN1KMT2A
SCHEMBL19244815 0.76 ACP3 (0.40) ACP3CES2NPSR1ALDH1A1CYP3A4
SCHEMBL17533972 0.76 CA12 (0.38) SMN1; SMN2MEN1KMT2AMMP2HSD11B1
SCHEMBL381185 0.75 ACP3 (0.47) ACP3CES2ALDH1A1CYP3A4CYP2C9
SCHEMBL15170368 0.75 ACP3 (0.47) ACP3CES2ALDH1A1CYP3A4CYP2C9
SCHEMBL19244821 0.74 ACP3 (0.39) ACP3CES2ALDH1A1CYP3A4CYP2C9
SCHEMBL16674214 0.74 PNMT (0.52) ACP3CES2ALDH1A1CYP3A4CYP2C9
SCHEMBL414657 0.74 ACP3 (0.43) ACP3CES2ALDH1A1CYP3A4CYP2C9
SCHEMBL380987 0.74 ALDH1A1 (0.40) ACP3CES2NPSR1ALDH1A1CYP3A4
SCHEMBL17533956 0.73 TAS2R14 (0.44) KAT6AGAAMEN1KMT2AMMP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2408751-B1 Substituted 2-acetamido-5-aryl-1,2,4-triazolones and use thereof BAYER IP GMBH (DE) 2017-08-23 EP disclosed
EP-2470530-A1 HETEROCYCLIC-SUBSTITUTED 2-ACETAMIDO-5-ARYL-1,2,4-TRIAZOLONES AND USE THEREOF Bayer Pharma Aktiengesellschaft (DE) 2012-07-04 EP disclosed
EP-2408751-A1 Substituted 2-acetamido-5-aryl-1,2,4-triazolones and use thereof Bayer Pharma Aktiengesellschaft (DE) 2012-01-25 EP disclosed
WO-2011023703-A1 HETEROCYCLIC-SUBSTITUTED 2-ACETAMIDO-5-ARYL-1,2,4-TRIAZOLONES AND USE THEREOF BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2011-03-03 WO disclosed
WO-2010105770-A1 SUBSTITUTED 2-ACETAMIDO-5-ARYL-1,2,4-TRIAZOLONES AND USE THEREOF BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2010-09-23 WO disclosed